Collaborative Drug Discovery
Private Company
Total funding raised: $3M
Overview
Collaborative Drug Discovery (CDD) is a private, revenue-generating software company founded in 2004, headquartered in Burlingame, California. The company's core product, CDD Vault, is a comprehensive, cloud-based informatics platform that centralizes research data management, collaboration, and analysis for drug discovery and related life sciences. By breaking down data silos and structuring information for machine learning, CDD enables research organizations to increase productivity, safeguard intellectual property, and accelerate the path to discovery. The company operates on a SaaS business model, serving hundreds of organizations globally with a strong emphasis on user-centric design and scientific customer support.
Technology Platform
CDD Vault: A cloud-based, unified scientific data management platform integrating modules for entity registration, assay data management, visualization, electronic lab notebook (ELN), inventory, curve analysis, and AI/ML tools. It is designed to structure, secure, and facilitate collaboration on chemistry and biology data for drug discovery and life sciences research.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Competes in the lab informatics and ELN market against companies like Dotmatics, Benchling (primarily for biology), IDBS, and various electronic lab notebook providers. Differentiation lies in its specific focus on collaborative, cloud-based discovery data for both chemistry and biology, its user-friendly design for rapid adoption, and its integrated AI/ML capabilities within a unified platform.